Campion Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Hold
816
0.19% 68
2026
Q1
$239K Sell
816
-79
-9% -$26K 0.16% 76
2025
Q4
$314K Hold
895
0.22% 62
2025
Q3
$289K Sell
895
-20
-2% -$6.22K 0.21% 70
2025
Q2
$356K Sell
915
-20
-2% -$8.04K 0.27% 61
2025
Q1
$407K Sell
935
-25
-3% -$10K 0.31% 60
2024
Q4
$354K Sell
960
-11
-1% -$4.6K 0.27% 61
2024
Q3
$505K Sell
971
-79
-8% -$42.2K 0.37% 51
2024
Q2
$569K Hold
1,050
0.45% 40
2024
Q1
$544K Hold
1,050
0.42% 50
2023
Q4
$495K Hold
1,050
0.42% 51
2023
Q3
$457K Hold
1,050
0.42% 53
2023
Q2
$467K Hold
1,050
0.42% 54
2023
Q1
$483K Hold
1,050
0.46% 49
2022
Q4
$539K Sell
1,050
-35
-3% -$17.8K 0.53% 46
2022
Q3
$493K Hold
1,085
0.52% 43
2022
Q2
$524K Hold
1,085
0.52% 43
2022
Q1
$533K Sell
1,085
-10
-0.9% -$4.57K 0.45% 47
2021
Q4
$508K Hold
1,095
0.42% 49
2021
Q3
$408K Hold
1,095
0.36% 58
2021
Q2
$418K Sell
1,095
-330
-23% -$126K 0.35% 55
2021
Q1
$512K Buy
+1,425
New +$458K 0.39% 54

Other funds holding ELV

Campion Asset Management's ELV Position: Q2 2026 in Review

Campion Asset Management held its Elevance Health (ELV) position steady in Q2 2026 at 816 shares worth $316K. The position accounts for 0.19% of the portfolio, ranked #68.

Campion Asset Management first reported a position in ELV in Q1 2021 and has held it in 22 quarters since. The position peaked at $569K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Campion Asset Management held 816 shares of Elevance Health worth $316K as of Q2 2026.
  • Campion Asset Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.19% of Campion Asset Management's portfolio in Q2 2026, its #68 holding.
  • Campion Asset Management first reported a position in Elevance Health in Q1 2021 and has held it in 22 quarters since.
  • Campion Asset Management's Elevance Health position peaked at $569K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Campion Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.